Product In Action Webinar
Thursday, August 15, 2024
1 PM EDT
In today's rapidly evolving healthcare landscape, timely and accurate microbial identification is crucial for effective patient care and combating antimicrobial resistance. Traditional methods often fall short in providing the speed and precision required, leading to delays in targeted therapy and contributing to the growing challenge of antimicrobial resistance.
Join us for an insightful webinar on the transformative advancements of the VITEK MS Prime. Discover how this cutting-edge mass spectrometry system offers enhanced speed, accuracy, and efficiency in microbial identification. Learn firsthand about the benefits to patients, as fast and precise identification leads to quicker targeted therapies and improving patient outcomes.
Moreover, explore the implications for antimicrobial stewardship, as the VITEK MS Prime empowers healthcare providers with actionable data for more informed treatment decisions, combating antimicrobial resistance. Don't miss this opportunity to delve into the future of diagnostic microbiology with experts who will showcase how bioMérieux is setting new standards in clinical microbiology with the VITEK MS Prime.
As an attendee, you will learn more about:
- Describe the main differences between the legacy MALDI and MALDI Prime
- Compare the laboratory workflow with the legacy MALDI compared to MALDI Prime
- Report the performance of the legacy MALDI as compared to the MALDI Prime for identification of mycobacteria and fungal organisms
Speaker
Caitlin Otto, PhD, D(ABMM)
Clinical Assistant Professor in Pathology and Director of Clinical Microbiology
NYU Langone Health